One academic believes that an excessive amount of resources is wasted on the hasty pursuance of drug trials, which don’t always generate conclusive results. However, UCLA Health officials think that the drug approval process is relatively efficient. Read more...
Photo: Jonathan Kimmelman, a biomedical ethics professor at McGill University, spoke to medical students and healthcare professionals about pharmaceutical ethics at the Ronald Reagan UCLA Medical Center on Tuesday. (Hannah Burnett/Daily Bruin)




